Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG

Journal of Nuclear Medicine

Volumn 39, Issue 12, 1998, Pages 2121-2127

  Uematsu, Hidemasa ^a   Sadato, Norihiro ^a   Yonekura, Yoshiharu ^a   Tsuchida, Tatsuro ^a   Nakamura, Satoshi ^a   Sugimoto, Katsuya ^a   Waki, Atsuo ^a   Yamamoto, Kazutaka ^a   Hayashi, Nobushige ^a   Ishii, Yasushi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Coregistration; FDG; Head and neck neoplasms; MRI; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REFERENCE VALUES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032422142     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-1757.
2. Lapera M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
3. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-216.
4. Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglueose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:455-464.
5. Greven KM, Williams DW, Keyers JW, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol Biol Phys 1994;29:841-845.
6. Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A, et al. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head Neck Surg 1995;121:272-276.
7. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991;32:623-648.
8. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996;37:1127-1129.
9. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-F-18 fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186: 27-35.
10. DeGrado TR, Turkington TG, Williams JJ, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406.
11. Kapouleas I, Alavi A, Alves WM, Gur RE, Weiss D. Registration of three-dimensional MR and PET images of the human brain without markers. Radiology 1991;181:731-739.
12. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991;32:1548-1555.
13. Kubota R, Yamada S, Kubota K, Ishikawa K, Tamahashi N, Ido T. Intra-tumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
14. Provenza DV. Tongue and tonsils. In: Provenza DV, ed. Oral histology: inheritance and development, 2nd ed. Philadelphia: Lea & Feiger, 1986:418-429.
15. Bhaskar SN. Salivary glands. In: Bhaskar SN, ed. Orban's oral histology and embryology. 8th ed. St. Louis: C.V. Mosby; 1976:328-360.
16. Di Chiro G, Oldfield E, Bairamian D, et al. Metabolic imaging of the brain stem and spinal cord: studies with positron emission tomography using 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr 1983;7:937-945.
17. Kamoto Y, Sadato N, Yonekura Y, et al. Visualization of cervical spinal cord with 18FDG and high resolution PET. J Comput Assist Tomogr 1998;22:487-491.
18. Phelps ME, Huang SC, Hoffman EJ, et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
19. Vogl T, Dresel S, Bilaniuk LT, et al. Tumors of the nasopharynx and adjacent areas: MR imaging with Gd-DTPA. AJR 1990;154:585-592.
20. Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT. Accurate three-dimensional registration of CT, PET, and or MR images of the brain. J Comput Assist Tomogr 1989;13:20-26.
21. Holman BL, Zimmerman RE, Johnson KA, et al. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain. J Nucl Med 1991;32:1478-1484.
22. Scott AM, Macapinlac II, Zhang J, et al. Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer. J Nucl Med 1995;36:100-103.
23. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-2018.
24. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190-1197.
25. Wong WL, Hussain K, Chevretton E, et al. Validation and clinical application of computer-combined emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 1996;172:628-632.